CD4 count monitoring seldom contributes to clinical‐decision making

By  

HIV MEDICINE, Vol. 16, Iss. 3, 2015-03 ,pp. : 196-200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre‐therapy inflammation and coagulation activation and long‐term CD4 count responses to the initiation of antiretroviral therapy

By  

HIV MEDICINE, Vol. 16, Iss. 7, 2015-08 ,pp. : 449-454

John Wiley & Sons Inc

Access to resources Recommend Favorite

Body mass index and early CD4 T‐cell recovery among adults initiating antiretroviral therapy in North America, 1998–2010

By  

HIV MEDICINE, Vol. 16, Iss. 9, 2015-10 ,pp. : 572-577

John Wiley & Sons Inc

Access to resources Recommend Favorite

Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada

By  

HIV MEDICINE, Vol. 16, Iss. 6, 2015-07 ,pp. : 337-345

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion

By  

HIV MEDICINE, Vol. 19, Iss. 3, 2018-03 ,pp. : 184-194

John Wiley & Sons Inc

Access to resources Recommend Favorite